Literature DB >> 19417008

Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1.

Audrey Sabbagh1, Eric Pasmant, Ingrid Laurendeau, Béatrice Parfait, Sébastien Barbarot, Bernard Guillot, Patrick Combemale, Salah Ferkal, Michel Vidaud, Patrick Aubourg, Dominique Vidaud, Pierre Wolkenstein.   

Abstract

Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder which displays considerable inter- and intra-familial variability in phenotypic expression. To evaluate the genetic component of variable expressivity in NF1, we examined the phenotypic correlations between affected relatives in 750 NF1 patients from 275 multiplex families collected through the NF-France Network. Twelve NF1-related clinical features, including five quantitative traits (number of café-au-lait spots of small size and of large size, and number of cutaneous, subcutaneous and plexiform neurofibromas) and seven binary ones, were scored. All clinical features studied, with the exception of neoplasms, showed significant familial aggregation after adjusting for age and sex. For most of them, patterns of familial correlations indicated a strong genetic component with no apparent influence of the constitutional NF1 mutation. Heritability estimates of the five quantitative traits ranged from 0.26 to 0.62. Moreover, we investigated for the first time the role of the normal NF1 allele in the variable expression of NF1 through a family-based association study. Nine tag SNPs in NF1 were genotyped in 1132 individuals from 313 NF1 families. No significant deviations of transmission of any of the NF1 variants to affected offspring was found for any of the 12 clinical features examined, based on single marker or haplotype analysis. Taken together, our results provided evidence that genetic modifiers, unlinked to the NF1 locus, contribute to the variable expressivity of the disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19417008      PMCID: PMC2722187          DOI: 10.1093/hmg/ddp212

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  Evaluation of genotype-phenotype correlations in neurofibromatosis type 1.

Authors:  B Castle; M E Baser; S M Huson; D N Cooper; M Upadhyaya
Journal:  J Med Genet       Date:  2003-10       Impact factor: 6.318

3.  Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics.

Authors:  Steve Horvath; Xin Xu; Stephen L Lake; Edwin K Silverman; Scott T Weiss; Nan M Laird
Journal:  Genet Epidemiol       Date:  2004-01       Impact factor: 2.135

4.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

5.  Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2.

Authors:  M Venturin; P Guarnieri; F Natacci; M Stabile; R Tenconi; M Clementi; C Hernandez; P Thompson; M Upadhyaya; L Larizza; P Riva
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

6.  Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.

Authors:  C Mattocks; D Baralle; P Tarpey; C ffrench-Constant; M Bobrow; J Whittaker
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

7.  A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.

Authors:  Dale R Nyholt
Journal:  Am J Hum Genet       Date:  2004-03-02       Impact factor: 11.025

8.  Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).

Authors:  J Szudek; H Joe; J M Friedman
Journal:  Genet Epidemiol       Date:  2002-08       Impact factor: 2.135

9.  Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients.

Authors:  E Ars; H Kruyer; M Morell; E Pros; E Serra; A Ravella; X Estivill; C Lázaro
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

10.  Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene.

Authors:  Lan Kluwe; Reiner Siebert; Stefan Gesk; Reinhard E Friedrich; Sigrid Tinschert; Hildegard Kehrer-Sawatzki; Victor-F Mautner
Journal:  Hum Mutat       Date:  2004-02       Impact factor: 4.878

View more
  53 in total

1.  Back to the future: proceedings from the 2010 NF Conference.

Authors:  Susan M Huson; Maria T Acosta; Allan J Belzberg; Andre Bernards; Jonathan Chernoff; Karen Cichowski; D Gareth Evans; Rosalie E Ferner; Marco Giovannini; Bruce R Korf; Robert Listernick; Kathryn N North; Roger J Packer; Luis F Parada; Juha Peltonen; Vijaya Ramesh; Karlyne M Reilly; John W Risner; Elizabeth K Schorry; Meena Upadhyaya; David H Viskochil; Yuan Zhu; Kim Hunter-Schaedle; Filippo G Giancotti
Journal:  Am J Med Genet A       Date:  2010-12-22       Impact factor: 2.802

Review 2.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

Review 3.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

4.  NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Authors:  Joseph A Toonen; Corina Anastasaki; Laura J Smithson; Scott M Gianino; Kairong Li; Robert A Kesterson; David H Gutmann
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

5.  NF1 single and multi-exons copy number variations in neurofibromatosis type 1.

Authors:  Apolline Imbard; Eric Pasmant; Audrey Sabbagh; Armelle Luscan; Magali Soares; Philippe Goussard; Hélène Blanché; Ingrid Laurendeau; Salah Ferkal; Michel Vidaud; Stéphane Pinson; Christine Bellanne-Chantelot; Dominique Vidaud; Pierre Wolkenstein; Béatrice Parfait
Journal:  J Hum Genet       Date:  2015-01-29       Impact factor: 3.172

6.  The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.

Authors:  A Pemov; H Li; R Patidar; N F Hansen; S Sindiri; S W Hartley; J S Wei; A Elkahloun; S C Chandrasekharappa; J F Boland; S Bass; J C Mullikin; J Khan; B C Widemann; M R Wallace; D R Stewart
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

Review 7.  Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.

Authors:  Verena Staedtke; Ren-Yuan Bai; Jaishri O'Neill Blakeley
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 8.  Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells.

Authors:  Karl Staser; Feng-Chun Yang; David W Clapp
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

9.  The mutational spectrum of the NF1 gene in neurofibromatosis type I patients from UAE.

Authors:  Salma Ben-Salem; Aisha M Al-Shamsi; Bassam R Ali; Lihadh Al-Gazali
Journal:  Childs Nerv Syst       Date:  2014-01-11       Impact factor: 1.475

10.  Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis.

Authors:  German Melean; Alba Marina Hernández; María Carmen Valero; Elisabete Hernández-Imaz; Yolanda Martín; Concepción Hernández-Chico
Journal:  BMC Cancer       Date:  2010-08-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.